FARALLON CAPITAL MANAGEMENT LLC
Registered adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Oct 2026 to Nov 2026 | $52,076,899,000 | Pooled investment vehicles (100%) |
| Apr 2026 to Sep 2026 | $52,076,899,000 | Pooled investment vehicles (100%) |
| Apr 2025 to Mar 2026 | $48,267,892,000 | Pooled investment vehicles (100%) |
| Jul 2024 to Mar 2025 | $42,649,319,000 | Pooled investment vehicles (100%) |
| Apr 2024 to Jun 2024 | $42,649,319,000 | Pooled investment vehicles (100%) |
| May 2023 to Mar 2024 | $41,248,942,000 | Pooled investment vehicles (100%) |
Schedule 13D/13G stakes
Stakes of 5% or more disclosed on Schedule 13D or 13G, each on the filer's latest filing for the security. These are event-dated stakes, not the quarter-end 13F portfolio below.
| Company | Schedule | Event date | Filed | Shares | % of class | Status |
|---|---|---|---|---|---|---|
| EXEL Exelixis, Inc. | 13G | Nov 9, 2026 | 10d | 14,694,910 | 6% | Current |
| AVTX Avalo Therapeutics, Inc. | 13G | Sep 30, 2026 | 6d | 3,974,000 | 7.4% | Current |
| BBIO BridgeBio Pharma, Inc. | 13G/A | Sep 30, 2026 | 7d | 14,247,000 | 7.3% | Current |
| AGIO Agios Pharmaceuticals, Inc. | 13G/A | Jun 30, 2026 | 4mo | 5,917,400 | 9.9% | Current |
| ASMB Assembly Biosciences, Inc. | 13G/A | Jun 30, 2026 | 4mo | 1,604,590 | 8.1% | Current |
| BEAM Beam Therapeutics Inc. | 13G/A | Jun 30, 2026 | 3mo | 10,282,210 | 9.99% | Current |
| GRAL GRAIL, Inc. | 13G/A | Jun 30, 2026 | 3mo | 4,161,584 | 9.6% | Current |
| LQDA Liquidia Corp | 13G/A | Jun 30, 2026 | 4mo | 8,365,038 | 9.4% | Current |
| NERV Minerva Neurosciences, Inc. | 13G/A | Jun 30, 2026 | 3mo | 4,730,000 | 9.7% | Current |
| PTGX Protagonist Therapeutics, Inc | 13G/A | Jun 30, 2026 | 3mo | 6,433,119 | 9.99% | Current |
| RVMD Revolution Medicines, Inc. | 13G/A | Jun 30, 2026 | 3mo | 13,564,149 | 6.4% | Current |
| SVRA Savara Inc | 13G/A | Jun 30, 2026 | 3mo | 15,000,000 | 6.8% | Current |
A 13D or 13G stays in force until its filer amends it and no amendment is due without a material change, so a stake with no filing in 24 months reads unconfirmed, never sold. An amendment reporting under 5% ends the filer's duty to amend, not necessarily the holding. Shares are restated onto today's split basis. Show 10 exited, below-5% or retired stakes
Portfolio style
Measured from the filed 13F common-share book for Sep 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 1000 as of 2026-09-30, active share 89.5%; sector active share 60.9% against the combined 13F book's sector weights.
Over time 27 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+. Stocks and the top 10 weight count issuers: share classes of one company are one stock, and options are left out, so they can differ from the position count and top 10 concentration of GetInstitutionSummary and GetInstitutionPortfolio, which count each listed share class.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
109 common stock positions · as of Sep 30, 2026 · Δ vs Jun 30, 2026Portfolio Trend
Sector Breakdown
Common stock positions · as of Sep 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 64.8% | $12,021,104,170 |
| Communication Services | 12.6% | $2,346,923,419 |
| Technology | 7.0% | $1,306,893,268 |
| Financial Services | 4.2% | $775,587,425 |
| Consumer Cyclical | 3.3% | $620,286,455 |
| Industrials | 2.9% | $543,439,793 |
| Basic Materials | 2.6% | $477,543,868 |
| Consumer Defensive | 2.4% | $451,545,010 |
| Energy | 0.0% | $6,637,209 |
| Real Estate | 0.0% | $5,057,240 |
| Utilities | 0.0% | $4,905,900 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| — | +21,272,344 | 49,372,344 | $1,528,074,046 | ||
| ROIV | Roivant Sciences Ltd. | +7,436,533 | 21,745,533 | $795,234,141 | |
| BBIO | BridgeBio Pharma, Inc. | +3,503,937 | 14,247,000 | $937,452,600 | |
| FRNM | Freenome, Inc. | +1,483,757 | 3,733,757 | $58,806,672 | |
| AVTX | Avalo Therapeutics, Inc. | +1,476,000 | 3,974,000 | $60,921,420 | |
| EXEL | Exelixis, Inc. | +1,226,900 | 14,694,910 | $858,329,693 | |
| ARMK | Aramark | +980,700 | 4,606,431 | $246,674,380 | |
| BSX | Boston Scientific Corp | +765,980 | 11,287,164 | $492,684,708 | |
| IMVT | Immunovant, Inc. | +666,000 | 6,471,000 | $218,590,380 | |
| BIIB | Biogen Inc. | +609,868 | 680,868 | $153,794,463 | |
| LQDA | Liquidia Corp | +541,000 | 8,906,038 | $269,496,709 | |
| ACHC | Acadia Healthcare Company, Inc. | +387,600 | 4,608,400 | $126,731,000 | |
| NTRA | Natera, Inc. | +381,282 | 2,599,648 | $1,074,460,514 | |
| BTSG | BrightSpring Health Services, Inc. | +311,000 | 2,043,800 | $115,985,650 | |
| AVGO | Broadcom Inc. | +244,010 | 1,395,810 | $490,194,513 | |
| JOYY | JOYY Inc. | +121,000 | 820,200 | $65,821,050 | |
| PTGX | Protagonist Therapeutics, Inc | +89,000 | 6,437,906 | $907,036,576 | |
| JNJ | Johnson & Johnson | +72,426 | 480,426 | $127,187,979 | |
| BEAM | Beam Therapeutics Inc. | +40,000 | 10,276,396 | $251,257,882 | |
| RIO | Rio Tinto PLC | +35,424 | 218,899 | $20,613,718 | |
| VNET | VNET Group, Inc. | +33,000 | 2,025,000 | $11,238,750 | |
| SNPS | Synopsys Inc | +28,290 | 857,890 | $373,130,676 | |
| AGIO | Agios Pharmaceuticals, Inc. | +22,000 | 5,939,400 | $197,485,050 | |
| ABVX | Abivax S.A. | +18,000 | 140,000 | $13,862,800 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | −7,726,312 | 4,550,688 | $113,539,665 | |
| LNTH | Lantheus Holdings, Inc. | −2,472,225 | 3,111,254 | $309,663,110 | |
| ENTA | Enanta Pharmaceuticals Inc | −1,468,202 | 950,000 | $12,521,000 | |
| MOBI | Mobia Medical, Inc. | −690,729 | 437,828 | $4,137,474 | |
| TMO | Thermo Fisher Scientific Inc. | −603,500 | 445,685 | $300,859,659 | |
| MSFT | Microsoft Corp | −379,300 | 733,563 | $376,244,462 | |
| AMZN | Amazon Com Inc | −264,530 | 2,368,464 | $590,102,805 | |
| KKR | KKR & Co. Inc. | −238,280 | 3,880,020 | $354,245,826 | |
| UNH | Unitedhealth Group Inc | −221,910 | 1,048,622 | $384,928,163 | |
| AON | Aon plc | −142,890 | 1,239,672 | $343,104,019 | |
| AZN | Astrazeneca PLC | −134,000 | 440,000 | $71,046,800 | |
| RVMD | Revolution Medicines, Inc. | −132,000 | 13,418,796 | $2,754,342,066 | |
| NVS | Novartis AG | −108,000 | 255,000 | $36,355,350 | |
| GRAL | GRAIL, Inc. | −92,351 | 4,069,233 | $570,180,927 | |
| NVNIW | Nvni Group Ltd | −43,600 | 331,400 | $5,932 | |
| GH | Guardant Health, Inc. | −42,500 | 279,700 | $49,887,292 | |
| WAB | Westinghouse Air Brake Technologies Corp | −16,600 | 877,903 | $252,116,183 | |
| SGMT | Sagimet Biosciences Inc. | −15,000 | 400,000 | $3,952,000 | |
| IFRX | InflaRx N.V. | −15,000 | 3,310,000 | $5,958,000 | |
| TSHA | Taysha Gene Therapies, Inc. | −1,000 | 2,249,000 | $10,952,630 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ROKU | Roku, Inc | 4,160,049 | $633,492,261 | |
| CRH | Crh Public Ltd Co | 5,341,100 | $442,243,080 | |
| IOND | Ionic Digital Inc. | 718,123 | $57,686,820 | |
| LBRX | Lb Pharmaceuticals Inc | 741,410 | $28,455,315 | |
| IMCR | Immunocore Holdings plc | 928,000 | $28,109,120 | |
| ASML | Asml Holding NV | 13,518 | $24,490,155 | |
| BABA | Alibaba Group Holding Ltd | 189,000 | $20,325,060 | |
| ETRA | Electra Therapeutics, Inc. | 1,700,000 | $19,125,000 | |
| LTGO | Latigo Biotherapeutics, Inc. | 850,000 | $14,195,000 | |
| SCTX | Scribe Therapeutics, Inc. | 380,000 | $6,993,900 | |
| COHU | Cohu Inc | 91,000 | $6,200,740 | |
| ENTG | Entegris Inc | 37,000 | $5,700,220 | |
| BRVE | Braveheart Bio, Inc. | 277,778 | $5,611,115 | |
| CLS | Celestica Inc | 15,000 | $5,421,450 | |
| RVTY | Revvity, Inc. | 35,000 | $5,351,150 | |
| VEEV | Veeva Systems Inc | 18,500 | $5,280,825 | |
| ROK | Rockwell Automation, Inc | 12,000 | $5,223,960 | |
| GTES | Gates Industrial Corp Ltd. | 196,000 | $5,135,200 | |
| MH | McGraw Hill, Inc. | 389,000 | $5,099,790 | |
| ECL | Ecolab Inc. | 18,500 | $5,079,730 | |
| WOR | Worthington Enterprises, Inc. | 85,000 | $5,060,900 | |
| ATI | Ati Inc | 26,500 | $5,019,100 | |
| BLDR | Builders FirstSource, Inc. | 87,000 | $4,959,870 | |
| NKE | NIKE, Inc. | 140,000 | $4,956,000 | |
| RPM | Rpm International Inc | 50,000 | $4,933,500 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 7,919,500 | $1,623,814,280 | ||
| — | 8,989,098 | $336,372,047 | ||
| — | 1,060,000 | $140,693,800 | ||
| NVO | Novo Nordisk A S | 2,619,000 | $125,554,860 | |
| MRK | Merck & Co., Inc. | 199,000 | $25,571,500 | |
| WRBY | Warby Parker Inc. | 828,000 | $25,121,520 | |
| AXTA | Axalta Coating Systems Ltd. | 478,000 | $16,357,160 | |
| BBNX | Beta Bionics, Inc. | 595,000 | $9,323,650 | |
| SMG | Scotts Miracle-Gro Co | 88,000 | $5,993,680 | |
| WAY | Waystar Holding Corp. | 264,900 | $5,438,397 | |
| BC | Brunswick Corp | 61,000 | $5,138,640 | |
| GNTX | Gentex Corp | 199,000 | $5,028,730 | |
| IDXX | Idexx Laboratories Inc | 9,000 | $4,737,960 | |
| CMC | COMMERCIAL METALS Co | 67,000 | $4,204,250 | |
| TEVA | Teva Pharmaceutical Industries Ltd | 40,000 | $1,355,200 | |
| ANNAW | AleAnna, Inc. | 990,000 | $297,000 | |
| ANNA | AleAnna, Inc. | 78,400 | $227,360 | |
| SLDPW | Solid Power, Inc. | 405,316 | $41,423 | |
| BGLWW | Blue Gold Ltd | 255,800 | $30,696 | |
| BYND | Beyond Meat, Inc. | 633 | $14,249 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
PUT
|
Reduced | 5,220,000 | $3,980,928,600 | 17.63% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 13,418,796 | $2,754,342,066 | 12.20% | |
|
|
Added | 49,372,344 | $1,528,074,046 | 6.77% | ||
| NTRA |
Natera, Inc.
Healthcare
|
Added | 2,599,648 | $1,074,460,514 | 4.76% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 14,247,000 | $937,452,600 | 4.15% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Added | 6,437,906 | $907,036,576 | 4.02% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
Added | 14,694,910 | $858,329,693 | 3.80% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 21,745,533 | $795,234,141 | 3.52% | |
| ROKU |
Roku, Inc
Communication Services
|
NEW | 4,160,049 | $633,492,261 | 2.81% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
Reduced | 2,368,464 | $590,102,805 | 2.61% | |
| GRAL |
GRAIL, Inc.
Healthcare
|
Reduced | 4,069,233 | $570,180,927 | 2.52% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 11,287,164 | $492,684,708 | 2.18% | |
| AVGO |
Broadcom Inc.
Technology
|
Added | 1,395,810 | $490,194,513 | 2.17% | |
| CRH |
Crh Public Ltd Co
Basic Materials
|
NEW | 5,341,100 | $442,243,080 | 1.96% | |
| KVUE |
Kenvue Inc.
Consumer Defensive
|
Held | 25,015,000 | $441,764,900 | 1.96% | |
| TWST |
Twist Bioscience Corp
Healthcare
|
Held | 2,136,400 | $412,837,936 | 1.83% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Reduced | 1,048,622 | $384,928,163 | 1.70% | |
| MSFT |
Microsoft Corp
Technology
|
Reduced | 733,563 | $376,244,462 | 1.67% | |
| SNPS |
Synopsys Inc
Technology
|
Added | 857,890 | $373,130,676 | 1.65% | |
| KKR |
KKR & Co. Inc.
Financial Services
|
Reduced | 3,880,020 | $354,245,826 | 1.57% | |
| AON |
Aon plc
Financial Services
|
Reduced | 1,239,672 | $343,104,019 | 1.52% | |
| LNTH |
Lantheus Holdings, Inc.
Healthcare
|
Reduced | 3,111,254 | $309,663,110 | 1.37% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Reduced | 445,685 | $300,859,659 | 1.33% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 8,906,038 | $269,496,709 | 1.19% | |
| WAB |
Westinghouse Air Brake Technologies Corp
Industrials
|
Reduced | 877,903 | $252,116,183 | 1.12% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Added | 10,276,396 | $251,257,882 | 1.11% | |
| ARMK |
Aramark
Industrials
|
Added | 4,606,431 | $246,674,380 | 1.09% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Added | 6,471,000 | $218,590,380 | 0.97% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 5,939,400 | $197,485,050 | 0.87% | |
| BIIB |
Biogen Inc.
Healthcare
|
Added | 680,868 | $153,794,463 | 0.68% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Added | 480,426 | $127,187,979 | 0.56% | |
| ACHC |
Acadia Healthcare Company, Inc.
Healthcare
|
Added | 4,608,400 | $126,731,000 | 0.56% | |
| BTSG |
BrightSpring Health Services, Inc.
Healthcare
|
Added | 2,043,800 | $115,985,650 | 0.51% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 4,550,688 | $113,539,665 | 0.50% | |
| BIDU |
Baidu, Inc.
Communication Services
|
Held | 1,203,785 | $104,572,802 | 0.46% | |
| PBLS |
Parabilis Medicines, Inc.
Healthcare
|
Held | 2,368,200 | $76,469,178 | 0.34% | |
| AZN |
Astrazeneca PLC
Healthcare
|
Reduced | 440,000 | $71,046,800 | 0.31% | |
| JOYY |
JOYY Inc.
Communication Services
|
Added | 820,200 | $65,821,050 | 0.29% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 3,974,000 | $60,921,420 | 0.27% | |
| FRNM |
Freenome, Inc.
Healthcare
|
Added | 3,733,757 | $58,806,672 | 0.26% | |
| IOND |
Ionic Digital Inc.
Financial Services
|
NEW | 718,123 | $57,686,820 | 0.26% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Reduced | 279,700 | $49,887,292 | 0.22% | |
| IBIT |
iShares Bitcoin Trust ETF
PUT
|
NEW | 916,800 | $43,401,312 | 0.19% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Held | 1,604,590 | $37,691,819 | 0.17% | |
| NVS |
Novartis AG
Healthcare
|
Reduced | 255,000 | $36,355,350 | 0.16% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Held | 1,107,814 | $30,110,384 | 0.13% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
NEW | 741,410 | $28,455,315 | 0.13% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
NEW | 928,000 | $28,109,120 | 0.12% | |
| ASML |
Asml Holding NV
Technology
|
NEW | 13,518 | $24,490,155 | 0.11% | |
| RIO |
Rio Tinto PLC
Basic Materials
|
Added | 218,899 | $20,613,718 | 0.09% |
Showing the top 50 of 111 positions. Create a free account to see every position, past quarters, search, filters and CSV export.
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.